Analyzing the Q3 and Q4 2022 holdings of hedge fund Aristotle Atlantic Partners, LLC: Significant Changes and Implications.

Aristotle Atlantic Partners, LLC is a hedge fund that has experienced noteworthy changes in its holdings over Q3 and Q4 of 2022, according to the 13F holdings comparison CSV file. The CSV file includes data on the holdings of the fund as well as comparisons between the two quarters in terms of shares and value. In this blog, we'll take a closer look at the changes in holdings of this fund and analyze the significance of these changes.

The CSV file includes data on the top holdings of the fund, including Microsoft (MSFT), Apple (AAPL), Alphabet (GOOGL), and Visa (V). Microsoft saw an increase in shares by 5,206, bringing its total number of shares to 619,505. The value of the shares also increased from $143,070 in Q3 to $148,569 in Q4, a change of 3.8%.

Apple, on the other hand, saw an increase in shares by 10,224, bringing its total number of shares to 786,819. However, the value of the shares decreased from $107,326 in Q3 to $102,231 in Q4, a change of -4.7%. Alphabet saw a similar trend, increasing its shares by 9,804 to 779,274, but with a decrease in value from $73,600 to $68,755, a change of -6.6%.

One of the most notable changes in holdings was seen with Amazon (AMZN), which saw increased shares by 3,397 to 710,078 in Q4. However, the value of the shares decreased drastically from $79,855 in Q3 to $59,646 in Q4, a change of -25.3%. This indicates that the fund may be losing confidence in Amazon's stock, possibly due to recent controversies surrounding the company.

Another notable change was with Merck & Co (MRK), which saw no change in shares, but a significant increase in value from $45,369 in Q3 to $58,449 in Q4, a change of 28.8%. This indicates that the fund has increased its confidence in the stock of Merck & Co, possibly due to positive developments within the company or the pharmaceutical industry as a whole.

Visa saw a smaller increase in shares by 1,981 to a total of 304,443, but a significant increase in value from $53,733 in Q3 to $63,251 in Q4, a change of 17.7%. This indicates that the fund has increased its confidence in the stock of Visa, potentially due to the ongoing growth of the financial technology industry and the increasing reliance on electronic payments.

The CSV file also includes data on some of the fund's smaller holdings, such as Iovance Biotherapeutics Inc (IOVA), which saw a decrease in shares by 8,213 to 1,008,436 in Q4, and a significant decrease in value from $9,740 in Q3 to $6,443 in Q4, a change of -33.8%. PotlatchDeltic Corporation (PCH), on the other hand, saw no change in shares or value, indicating that the fund's confidence in the stock has remained the same.

It's worth noting that some holdings listed in the CSV file, such as KLA Corp (KLAC), saw no shares or value listed in Q3 and a large increase in shares and value listed in Q4. It's unclear whether this is due to an error in reporting or an intentional change in holdings by the fund.

Overall, the changes in holdings of Aristotle Atlantic Partners, LLC over Q3 and Q4 of 2022 suggest that the fund is actively making adjustments to its portfolio based on various factors such as performance, news, and the overall market climate. While some holdings have seen increases in confidence, others have seen decreases, indicating that the fund is actively managing its investments to maximize returns and reduce risks. Investors should take note of these changes and consider them when making their own investment decisions.